{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:45:07Z","timestamp":1791006307483,"version":"4.1.0"},"reference-count":22,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["The American Surgeon\u2122"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>\n                    Platelet inhibition is known to occur after traumatic brain injury (TBI) and is predictive of bleed progression. The relationship between platelet inhibition and modified brain injury guideline (mBIG) score, however, is unknown. We hypothesize that patients with higher mBIG scores are more likely to have platelet inhibition and bleed progression. Methods: A practice management guideline was established calling for a thromboelastography with platelet mapping (TEG-PM) on all adult trauma patients with an intracranial hemorrhage. Patients were then categorized per the mBIG as 1, 2, or 3. Data was retrospectively collected from December 2019 to December 2021. Patients were considered to have platelet inhibition if the percent arachidonic acid (AA) or percent adenosine diphosphate (ADP) inhibition was \u226560% on TEG-PM. Results: Between December 2019 and December 2021, 768 patients underwent TEG-PM. AA inhibition was more likely to occur in mBIG 3 patients (26.3%) compared to mBIG 1 or mBIG 2 patients (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.08),. ADP and combined AA\/ADP inhibition were similar between mBIG scores. Modified BIG 3 patients were more likely to experience bleed progression compared to mBIG 1 or 2 (46.4%;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001) and to require neurosurgical intervention (16.5%; p &lt; 0.001). Discussion: Our study suggests that the higher the mBIG scores, the more likely patients will have worse outcomes regardless of platelet inhibition. Patients with TBI who experience worse outcomes is multifactorial in nature. TEG-PM should be used in conjunction with clinical judgement for treatment guidance.\n                  <\/jats:p>","DOI":"10.1177\/00031348251363523","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:31:21Z","timestamp":1753990281000},"page":"345-352","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of Modified BIG Scores and Platelet Inhibition in Patients with Traumatic Brain Injuries"],"prefix":"10.1177","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6897-1773","authenticated-orcid":false,"given":"Hunter W.","family":"Parmer","sequence":"first","affiliation":[{"name":"University of Tennessee College of Medicine Chattanooga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Victoria P.","family":"Miles","sequence":"additional","affiliation":[{"name":"University of Tennessee College of Medicine Chattanooga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chace","family":"Hicks","sequence":"additional","affiliation":[{"name":"University of Tennessee College of Medicine Chattanooga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Favors","sequence":"additional","affiliation":[{"name":"University of Tennessee College of Medicine Chattanooga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Rippy","sequence":"additional","affiliation":[{"name":"Erlanger Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wilson","sequence":"additional","affiliation":[{"name":"University of Tennessee Chattanooga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Edwards","sequence":"additional","affiliation":[{"name":"University of Tennessee College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Stewart","sequence":"additional","affiliation":[{"name":"Erlanger Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Maxwell","sequence":"additional","affiliation":[{"name":"University of Tennessee College of Medicine Chattanooga"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"Peterson A Zhou H Thomas K Daugherty J. Surveillance report of traumatic brain injury-related hospitalizations and deaths by age group sex and mechanism of injury\u2014United States 2016 and 2017. [Internet]. 2021 [cited 2021 Jul 13]. Available from: https:\/\/www.cdc.gov\/traumaticbraininjury\/pdf\/TBI-surveillance-report-2016-2017-508.pdf"},{"key":"e_1_3_4_3_2","unstructured":"Peterson AB Thomas KE Zhou H. Surveillance report of traumatic brain injury-related deaths by age group sex and mechanism of injury\u2014United States 2018 and 2019. [Internet]. 2022 [cited 2022 Nov 25]. Available from: https:\/\/www.cdc.gov\/traumaticbraininjury\/pdf\/tbi-surveillance-report-2018-2019-508.pdf"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/HTR.0000000000000573"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001199-199912000-00009"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2015.320"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3182a9cc95"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30197-7"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05275.x"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-012-9745-6"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000002171"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/02699052.2018.1536805"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000003516"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000002521"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000000161"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000003554"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2020-000483"},{"issue":"12","key":"e_1_3_4_18_2","first-page":"1147","article-title":"Blood-brain barrier disruption is an early event that may persist for many years after traumatic brain injury in humans","volume":"74","author":"Hay JR","year":"2015","unstructured":"Hay JR, Johnson VE, Young AM, Smith DH, Stewart W. Blood-brain barrier disruption is an early event that may persist for many years after traumatic brain injury in humans. J Neuropathol Exp Neurol. 2015;74(12):1147-1157.","journal-title":"J Neuropathol Exp Neurol"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000002047"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2012.01.050"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2009.12.044"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2020.7301"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16971"}],"container-title":["The American Surgeon\u2122"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00031348251363523","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00031348251363523","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00031348251363523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:38:15Z","timestamp":1777379895000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00031348251363523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1177\/00031348251363523"],"URL":"https:\/\/doi.org\/10.1177\/00031348251363523","relation":{},"ISSN":["0003-1348","1555-9823"],"issn-type":[{"value":"0003-1348","type":"print"},{"value":"1555-9823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}